Date: August 19, 2026
KMP / Board / Auditor Changes
Not Specified
Dividend Declaration or Non-Declaration
Not Specified
Board Meeting Outcomes
Not Specified
Financial Results (Standalone & Consolidated)
Not Specified
Disinvestment / Strategic Actions
Not Specified
Other Operational / Legal / Strategic Disclosures
Pledge Release and NCD Redemption Disclosure:
- Thyrocare Technologies Limited received communication from Docon Technologies Private Limited regarding complete discharge of obligations under Non-Convertible Debentures (NCDs)
- Catalyst Trusteeship Limited, acting as Debenture Trustee, issued No-Dues and Release Certificate on August 19, 2026
- The NCDs were issued by API Holdings Limited (ultimate holding company of Thyrocare Technologies Limited) aggregating to ₹1,700 crore
- The NCDs were secured by pledge of equity shares representing 60.92% of Thyrocare's equity share capital held by Docon Technologies Private Limited
- Upon full redemption and repayment of the NCDs by API Holdings Limited, the pledge has been fully released
- All Transaction Documents (Debenture Trust Deed, Debenture Trustee Agreement, Deed of Hypothecation, Share Pledge Agreements and Deeds of Guarantee) stand discharged and are no longer operative or effective
- Company confirms no impact on Thyrocare Technologies Limited from this termination
- Parties involved in the transaction:
1. Docon Technologies Private Limited
2. API Holdings Limited
3. AHWSPL India Private Limited
4. Catalyst Trusteeship Limited
- Initial disclosure of the execution of the agreement was made to stock exchanges on September 15, 2025
- Previous disclosures were also made on August 13, 2026 and August 17, 2026